Have a feature idea you'd love to see implemented?
Let us know!
ROIV Roivant Sciences Ltd
Price (delayed)
$11.82
Market cap
$8.6B
P/E Ratio
1.99
Dividend/share
N/A
EPS
$5.95
Enterprise value
$6.7B
Highlights
ROIV's gross profit has soared by 97% YoY
The debt has dropped by 89% year-on-year and by 86% since the previous quarter
The company's quick ratio has surged by 83% YoY but it has shrunk by 63% QoQ
ROIV's P/E is 4.7% above its last 4 quarters average of 1.9
ROIV's equity is down by 5% since the previous quarter
Key stats
What are the main financial stats of ROIV
Market
Valuations
Earnings
Shares outstanding
727.95M
Market cap
$8.6B
Enterprise value
$6.7B
Price to book (P/B)
1.7
Price to sales (P/S)
69.17
EV/EBIT
1.37
EV/EBITDA
1.36
EV/Sales
53.3
Revenue
$125.68M
EBIT
$4.88B
EBITDA
$4.91B
Free cash flow
-$781.21M
Per share
Balance sheet
Liquidity
EPS
$5.95
Free cash flow per share
-$1.06
Book value per share
$6.97
Revenue per share
$0.17
TBVPS
$8.44
Total assets
$6.21B
Total liabilities
$625.99M
Debt
$52.71M
Equity
$5.15B
Working capital
$5.24B
Debt to equity
0.01
Current ratio
10.43
Quick ratio
9.68
Net debt/EBITDA
-0.39
Margins
Efficiency
Dividend
EBITDA margin
3,906.1%
Gross margin
90.2%
Net margin
3,827.4%
Operating margin
3,447.7%
Return on assets
70.6%
Return on equity
85%
Return on invested capital
333.4%
Return on capital employed
86.4%
Return on sales
3,884.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ROIV stock price
How has the Roivant Sciences stock price performed over time
Intraday
2.87%
1 week
1.55%
1 month
1.72%
1 year
36.81%
YTD
5.25%
QTD
2.43%
Financial performance
How have Roivant Sciences's revenue and profit performed over time
Revenue
$125.68M
Gross profit
$113.39M
Operating income
$4.33B
Net income
$4.81B
Gross margin
90.2%
Net margin
3,827.4%
ROIV's gross profit has soared by 97% YoY
Roivant Sciences's revenue has surged by 80% YoY
The company's gross margin rose by 9% YoY
ROIV's operating margin is down by 3.5% since the previous quarter
Growth
What is Roivant Sciences's growth rate over time
Valuation
What is Roivant Sciences stock price valuation
P/E
1.99
P/B
1.7
P/S
69.17
EV/EBIT
1.37
EV/EBITDA
1.36
EV/Sales
53.3
ROIV's P/E is 4.7% above its last 4 quarters average of 1.9
The stock's price to book (P/B) is 82% less than its 5-year quarterly average of 9.7 but 13% more than its last 4 quarters average of 1.5
ROIV's equity is down by 5% since the previous quarter
Roivant Sciences's revenue has surged by 80% YoY
The stock's price to sales (P/S) is 7% less than its last 4 quarters average of 74.0
Efficiency
How efficient is Roivant Sciences business performance
The ROE has soared by 186% YoY but it is down by 17% QoQ
The ROIC has plunged by 50% from the previous quarter
ROIV's return on assets is down by 14% since the previous quarter
Dividends
What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ROIV.
Financial health
How did Roivant Sciences financials performed over time
The company's quick ratio has surged by 83% YoY but it has shrunk by 63% QoQ
Roivant Sciences's current ratio has surged by 79% YoY but it has shrunk by 63% QoQ
The debt is 99% smaller than the equity
The debt to equity has dropped by 98% year-on-year and by 86% since the previous quarter
The debt has dropped by 89% year-on-year and by 86% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.